Literature DB >> 21336964

Development of a tightly-regulated tetracycline-dependent transcriptional activator and repressor co-expression system for the strong induction of transgene expression.

Hiroshi Hosoda1, Takahisa Miyao, Shusaku Uchida, Shinsuke Sakai, Satoshi Kida.   

Abstract

The teteracycline (Tc)-dependent and -inducible transcriptional activator (rtTA) system has been used to express regulated transgene expression in vitro and in vivo. However, previous reports have demonstrated that, even in the absence of Tc, the rtTA binds weakly to the tetracycline response element (TRE), leading to a low level of background activity. In order to reduce the leaky gene expression induced by rtTA, we previously established a tightly regulated system (A-IRES-R system) that makes use of both the rtTA (A) and a Tc-dependent repressor (TetR-Kruppel-associated box; KRAB) (R). In addition, others have described a transactivator rtTA2-M2 (M2) that displays higher sensitivity to Dox than rtTA. In this study, to further develop the A-IRES-R system, we generated a derivative Tc system (M2-IRES-R system) that co-expresses both rtTA-M2 and TetR-KRAB from a single vector. We show that compared to the A-IRES-R system, the M2-IRES-R system leads to a greater level of induced TRE-mediated transcription in the presence of doxycycline (Dox) and yet displays a similar level of basal TRE-mediated transcription in the absence of Dox. Furthermore, the M2-IRES-R system also displays less leaky gene expression in the absence of Dox compared to rtTA-M2 and rtTA systems. Taken together, our results suggest that the M2-IRES-R system enables to tightly regulate and highly induce the expression of transgene compared to other systems.

Entities:  

Year:  2011        PMID: 21336964      PMCID: PMC3081044          DOI: 10.1007/s10616-011-9335-z

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  18 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances.

Authors:  U Baron; H Bujard
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Tight regulation of transgene expression by tetracycline-dependent activator and repressor in brain.

Authors:  S Uchida; S Sakai; T Furuichi; H Hosoda; K Toyota; T Ishii; A Kitamoto; M Sekine; K Koike; S Masushige; G Murphy; A J Silva; S Kida
Journal:  Genes Brain Behav       Date:  2006-02       Impact factor: 3.449

5.  Inducible and reversible gene expression with the rtTA system for the study of memory.

Authors:  I M Mansuy; D G Winder; T M Moallem; M Osman; M Mayford; R D Hawkins; E R Kandel
Journal:  Neuron       Date:  1998-08       Impact factor: 17.173

6.  A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells.

Authors:  S Freundlieb; C Schirra-Müller; H Bujard
Journal:  J Gene Med       Date:  1999 Jan-Feb       Impact factor: 4.565

7.  Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2.

Authors:  Arkadiusz Welman; Jane Barraclough; Caroline Dive
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

8.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

Authors:  A Kistner; M Gossen; F Zimmermann; J Jerecic; C Ullmer; H Lübbert; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Doxycycline control of prion protein transgene expression modulates prion disease in mice.

Authors:  P Tremblay; Z Meiner; M Galou; C Heinrich; C Petromilli; T Lisse; J Cayetano; M Torchia; W Mobley; H Bujard; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

10.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

View more
  3 in total

1.  A Sox10(rtTA/+) Mouse Line Allows for Inducible Gene Expression in the Auditory and Balance Organs of the Inner Ear.

Authors:  Bradley J Walters; Jian Zuo
Journal:  J Assoc Res Otolaryngol       Date:  2015-04-21

2.  Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters.

Authors:  S K Mungamuri; S Wang; J J Manfredi; W Gu; S A Aaronson
Journal:  Oncogene       Date:  2014-07-14       Impact factor: 9.867

3.  hTERT-Immortalized Bone Mesenchymal Stromal Cells Expressing Rat Galanin via a Single Tetracycline-Inducible Lentivirus System.

Authors:  Ke An; Hui-Ping Liu; Xiao-Long Zhong; David Y B Deng; Jing-Jun Zhang; Zhi-Heng Liu
Journal:  Stem Cells Int       Date:  2017-05-11       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.